Market Overview:
The Indian vaccine market is expected to exhibit a CAGR of
13.4% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
A vaccine is a biological substance that is developed to boost the immune system while protecting against bacterial and viral diseases. It comprises live attenuated, inactivated, toxoid, mRNA, viral vector, and subunit, recombinant, polysaccharide, and conjugate vaccines. It is consumed orally, by aerosol, or through injections to prevent several diseases, such as measles, polio, tetanus, influenza, rabies, and whooping cough. In addition, it stimulates the body to make antibodies against antigens or pathogens. At present, there is a rise in the production of vaccines in India due to technological advancements and the increasing number of cold chain storage facilities.
Indian Vaccine Market Trends:
The Government of India (GOI) is currently launching various campaigns, such as the Universal Immunization Program (UIP), to increase immunization coverage against vaccine-preventable diseases in the country. This, along with the growing health awareness among the masses, represents one of the key factors driving the market in India. Moreover, the rising export of generic medicines in India that imitates brand-name drugs in effect, strength, doses, qualities, forms, administration, and safety is contributing to the growth of the market. In addition, there is an increase in the number of private companies that are producing cost-effective vaccines and investing in their distribution throughout India. This, coupled with the burgeoning healthcare industry, is strengthening the growth of the market in the country. Besides this, key market players are extensively investing in research and development (R&D) activities to introduce new and enhanced vaccines. They are also focusing on developing innovative ways to distribute vaccines effectively within the country and international markets, which is catalyzing the demand for Indian vaccines. Other factors propelling the market growth are the increasing population, inflating income levels of individuals, improving existing vaccine infrastructure, the expanding logistics industry, and the growing participation of non-governmental organizations (NGOs).
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the Indian vaccine market report, along with forecasts at the global, regional, and country levels from 2022-2027. Our report has categorized the market based on monovalent and combined vaccines.
Breakup by Monovalent and Combined Vaccines:
- BCG
- HIB
- Influenza
- Varicella
- Typhoid
- Japanese Encephalitis
- Measles
- Tetanus Toxoid
- Hepatitis A
- Rubella
- Diphtheria
- Tetanus, and Pertussis (DPT)
- Oral Polio Vaccine (OPV)
- MMR
- Rotavirus
- Hepatitis B
- Pneumococcal
- Meningococcal
- Rabies
- HPV
- Hexavalent
- Dengue vaccines
The Focus of the Analysis for Each Vaccine
- Vaccine Overview
- Historical and Current Market Trends
- Market Breakup by Prescriber
- Market Breakup by Public and Private Sector
- Market Outlook
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Indian Vaccine Industry
5.1 Market Overview
5.2 Market Performance
5.2.1 Volume Trends
5.2.2 Value Trends
5.3 Impact of COVID-19
5.4 Market Breakup by Segment
5.5 Market Forecast
5.5.1 Volume Trends
5.5.2 Value Trends
6 Market Analysis of Various Monovalent and Combined Vaccines
6.1 BCG Vaccine Market
6.1.1 Vaccine Overview
6.1.2 Market Performance
6.1.3 Market Breakup by Prescriber
6.1.4 Market Breakup by Public and Private Sector
6.1.5 Market Forecast
6.2 HIB Vaccine Market
6.2.1 Vaccine Overview
6.2.2 Market Performance
6.2.3 Market Breakup by Prescriber
6.2.4 Market Breakup by Public and Private Sector
6.2.5 Market Forecast
6.3 Influenza Vaccine Market
6.3.1 Vaccine Overview
6.3.2 Market Performance
6.3.3 Market Breakup by Prescriber
6.3.4 Market Breakup by Public and Private Sector
6.3.5 Market Forecast
6.4 Varicella Vaccine Market
6.4.1 Vaccine Overview
6.4.2 Market Performance
6.4.3 Market Breakup by Prescriber
6.4.4 Market Breakup by Public and Private Sector
6.4.5 Market Forecast
6.5 Typhoid Vaccine Market
6.5.1 Vaccine Overview
6.5.2 Market Performance
6.5.3 Market Breakup by Prescriber
6.5.4 Market Breakup by Public and Private Sector
6.5.5 Market Forecast
6.6 Japanese Encephalitis Vaccine Market
6.6.1 Vaccine Overview
6.6.2 Market Performance
6.6.3 Market Breakup by Prescriber
6.6.4 Market Breakup by Public and Private Sector
6.6.5 Market Forecast
6.7 Measles Vaccine Market
6.7.1 Vaccine Overview
6.7.2 Market Performance
6.7.3 Market Breakup by Prescriber
6.7.4 Market Breakup by Public and Private Sector
6.7.5 Market Forecast
6.8 Tetanus Toxoid Vaccine Market
6.8.1 Vaccine Overview
6.8.2 Market Performance
6.8.3 Market Breakup by Prescriber
6.8.4 Market Breakup by Public and Private Sector
6.8.5 Market Forecast
6.9 Hepatitis A Vaccine Market
6.9.1 Vaccine Overview
6.9.2 Market Performance
6.9.3 Market Breakup by Prescriber
6.9.4 Market Breakup by Public and Private Sector
6.9.5 Market Forecast
6.10 Rubella Vaccine Market
6.10.1 Vaccine Overview
6.10.2 Market Performance
6.10.3 Market Breakup by Prescriber
6.10.4 Market Breakup by Public and Private Sector
6.10.5 Market Forecast
6.11 DPT (Diphtheria, Tetanus and Pertussis) Vaccine Market
6.11.1 Vaccine Overview
6.11.2 Market Performance
6.11.3 Market Breakup by Prescriber
6.11.4 Market Breakup by Public and Private Sector
6.11.5 Market Forecast
6.12 OPV (Oral Polio Vaccine) Vaccine Market
6.12.1 Vaccine Overview
6.12.2 Market Performance
6.12.3 Market Breakup by Prescriber
6.12.4 Market Breakup by Public and Private Sector
6.12.5 Market Forecast
6.13 MMR Vaccine Market
6.13.1 Vaccine Overview
6.13.2 Market Performance
6.13.3 Market Breakup by Prescriber
6.13.4 Market Breakup by Public and Private Sector
6.13.5 Market Forecast
6.14 Rotavirus Vaccine Market
6.14.1 Vaccine Overview
6.14.2 Market Performance
6.14.3 Market Breakup by Prescriber
6.14.4 Market Breakup by Public and Private Sector
6.14.5 Market Forecast
6.15 Hepatitis B Vaccine Market
6.15.1 Vaccine Overview
6.15.2 Market Performance
6.15.3 Market Breakup by Prescriber
6.15.4 Market Breakup by Public and Private Sector
6.15.5 Market Forecast
6.16 Pneumococcal Vaccine Market
6.16.1 Vaccine Overview
6.16.2 Market Performance
6.16.3 Market Breakup by Prescriber
6.16.4 Market Breakup by Public and Private Sector
6.16.5 Market Forecast
6.17 Meningococcal Vaccine Market
6.17.1 Vaccine Overview
6.17.2 Market Performance
6.17.3 Market Breakup by Prescriber
6.17.4 Market Breakup by Public and Private Sector
6.17.5 Market Forecast
6.18 Rabies Vaccine Market
6.18.1 Vaccine Overview
6.18.2 Market Performance
6.18.3 Market Breakup by Prescriber
6.18.4 Market Breakup by Public and Private Sector
6.18.5 Market Forecast
6.19 HPV Vaccine Market
6.19.1 Vaccine Overview
6.19.2 Market Performance
6.19.3 Market Breakup by Prescriber
6.19.4 Market Breakup by Public and Private Sector
6.19.5 Market Forecast
6.20 Hexavalent Vaccines
6.21 Dengue Vaccines
7 SWOT Analysis
7.1 Overview
7.2 Strengths
7.3 Weaknesses
7.4 Opportunities
7.5 Threats
8 Value Chain Analysis
8.1 Exploratory Stage
8.2 Preclinical and Clinical Development
8.3 Regulatory Approval
8.4 Manufacturing
8.5 Marketing and Distribution
9 Porter’s Five Forces Analysis
9.1 Overview
9.2 Bargaining Power of Supplier
9.3 Bargaining Power of Buyers
9.4 Degree of Competition
9.5 Threat of New Entrants
9.6 Threat of Substitutes
10 Competitive Landscape
10.1 Market Structure
10.2 Market Breakup by Key Players
11 Pricing Analysis
12 Regulatory Framework
13 Key Players Profiles
13.1 GlaxoSmithKline
13.2 Sanofi Aventis
13.3 Serum Institute of India
13.4 Panacea Biotec
13.5 Pfizer
13.6 Novartis
13.7 VHB Lifesciences
13.8 Zydus Cadila
13.9 MSD
List of Figures
Figure 1: India: Vaccine Market: Vaccine Development and Introduction
Figure 2: India: Vaccine Market: Major Drivers and Challenges
Figure 3: India: Vaccine Market: Doses Administered (in Million), 2016-2021
Figure 4: India: Vaccine Market: Sales Value (in INR Million), 2016-2021
Figure 5: India: Monovalent Vaccine Market: Value Breakup by Segment (in %), 2021
Figure 6: India: Combined Vaccine Market: Value Breakup by Segment (in %), 2021
Figure 7: India: Vaccine Market: Value Breakup by Age Group (in %), 2021
Figure 8: India: Vaccine Market Forecast: Doses Administered (in Million), 2022-2027
Figure 9: India: Vaccine Market Forecast: Sales Value Forecast (in INR Million), 2022-2027
Figure 10: India: BCG Vaccine Market: Doses Administered (in Million), 2016-2021
Figure 11: India: BCG Vaccine Market: Sales Value (in INR Million), 2016-2021
Figure 12: India: BCG Vaccine Market: Breakup by Prescriber (in %), 2021
Figure 13: India: BCG Vaccine Market: Breakup by Sector (in %), 2021
Figure 14: India: BCG Vaccine Market: Sales Value Forecast (in INR Million), 2022-2027
Figure 15: India: HIB Vaccine Market: Doses Administered (in Million), 2016-2021
Figure 16: India: HIB Vaccine Market: Sales Value (in INR Million), 2016-2021
Figure 17: India: HIB Vaccine Market: Breakup by Prescriber (in %), 2021
Figure 18: India: HIB Vaccine Market: Breakup by Sector (in %), 2021
Figure 19: India: HIB Vaccine Market: Sales Value Forecast (in INR Million), 2022-2027
Figure 20: India: Influenza Vaccine Market: Doses Administered (in Million), 2016-2021
Figure 21: India: Influenza Vaccine Market: Sales Value (in INR Million),
Figure 22: India: Influenza Vaccine Market: Breakup by Import and Domestic Manufacturing (in %), 2021
Figure 23: India: Influenza Vaccine Market: Breakup by Sector (in %), 2021
Figure 24: India: Influenza Vaccine Market: Sales Value Forecast (in INR Million), 2022-2027
Figure 25: India: Varicella Vaccine Market: Doses Administered (in Million), 2016-2021
Figure 26: India: Varicella Vaccine Market: Sales Value (in INR Million), 2016-2021
Figure 27: India: Varicella Vaccine Market: Breakup by Prescriber (in %), 2021
Figure 28: India: Varicella Vaccine Market: Breakup by Sector (in %), 2021
Figure 29: India: Varicella Vaccine Market: Sales Value Forecast (in INR Million), 2022-2027
Figure 30: India: Typhoid Vaccine Market: Doses Administered (in Million), 2016-2021
Figure 31: India: Typhoid Vaccine Market: Sales Value (in INR Million), 2016-2021
Figure 32: India: Typhoid Vaccine Market: Breakup by Prescriber (in %), 2021
Figure 33: India: Typhoid Vaccine Market: Breakup by Sector (in %), 2021
Figure 34: India: Typhoid Vaccine Market: Breakup by Type (in %), 2021
Figure 35: India: Typhoid Vaccine Market: Sales Value Forecast (in INR Million), 2022-2027
Figure 36: India: JE Vaccine Market: Doses Administered (in Million), 2016-2021
Figure 37: India: JE Vaccine Market: Sales Value (in INR Million), 2016-2021
Figure 38: India: JE Vaccine Market: Breakup by Prescriber (in %), 2021
Figure 39: India: JE Vaccine Market: Breakup by Sector (in %), 2021
Figure 40: India: JE Vaccine Market: Sales Value Forecast (in INR Million), 2022-2027
Figure 41: India: Measles Vaccine Market: Doses Administered (in Million), 2014 - 2016
Figure 42: India: Measles Vaccine Market: Sales Value (in INR Million), 2014 - 2016
Figure 43: India: Measles Vaccine Market: Breakup by Prescriber (in %), 2016
Figure 44: India: Measles Vaccine Market: Breakup by Sector (in %), 2016
Figure 45: India: Tetanus Toxoid Vaccine Market: Doses Administered (in Million), 2016-2021
Figure 46: India: Tetanus Toxoid Vaccine Market: Sales Value (in INR Million), 2016-2021
Figure 47: India: Tetanus Toxoid Vaccine Market: Breakup by Prescriber (in %), 2021
Figure 48: India: Tetanus Toxoid Vaccine Market: Breakup by Sector (in %), 2021
Figure 49: India: Hepatitis A Vaccine Market: Doses Administered (in Million), 2016-2021
Figure 50: India: Hepatitis A Vaccine Market: Sales Value (in INR Million), 2016-2021
Figure 51: India: Hepatitis A Vaccine Market: Breakup by Prescriber (in %), 2021
Figure 52: India: Hepatitis A Vaccine Market: Breakup by Sector (in %), 2021
Figure 53: India: Hepatitis A Vaccine Market: Sales Value Forecast (in INR Million), 2022-2027
Figure 54: India: Rubella Vaccine Market: Doses Administered (in Million), 2014 - 2016
Figure 55: India: Rubella Vaccine Market: Sales Value (in INR Million), 2014 - 2016
Figure 56: India: Rubella Vaccine Market: Breakup by Prescriber (in %), 2016
Figure 57: India: Rubella Vaccine Market: Breakup by Sector (in %), 2016
Figure 58: India: DPT Vaccine Market: Doses Administered (in Million), 2016-2021
Figure 59: India: DPT Vaccine Market: Sales Value (in INR Million), 2016-2021
Figure 60: India: DPT Vaccine Market: Breakup by Prescriber (in %), 2021
Figure 61: India: DPT Vaccine Market: Breakup by Sector (in %), 2021
Figure 62: India: DPT Vaccine Market: Sales Value Forecast (in INR Million), 2022-2027
Figure 63: India: OPV Vaccine Market: Doses Administered (in Million), 2016-2021
Figure 64: India: OPV Vaccine Market: Sales Value (in INR Million), 2016-2021
Figure 65: India: OPV Vaccine Market: Breakup by Prescriber (in %), 2021
Figure 66: India: OPV Vaccine Market: Breakup by Sector (in %), 2021
Figure 67: India: OPV Vaccine Market: Sales Value Forecast (in INR Million), 2022-2027
Figure 68: India: MMR Vaccine Market: Doses Administered (in Million), 2016-2021
Figure 69: India: MMR Vaccine Market: Sales Value (in INR Million), 2016-2021
Figure 70: India: MMR Vaccine Market: Breakup by Prescriber (in %), 2021
Figure 71: India: MMR Vaccine Market: Breakup by Sector (in %), 2021
Figure 72: India: MMR Vaccine Market: Sales Value Forecast (in INR Million), 2022-2027
Figure 73: India: Rotavirus Vaccine Market: Doses Administered (in Million), 2016-2021
Figure 74: India: Rotavirus Vaccine Market: Sales Value (in INR Million), 2016-2021
Figure 75: India: Rotavirus Vaccine Market: Breakup by Prescriber (in %), 2021
Figure 76: India: Rotavirus Vaccine Market: Breakup by Sector (in %), 2021
Figure 77: India: Rotavirus Vaccine Market: Sales Value Forecast (in INR Million), 2022-2027
Figure 78: India: Hepatitis B Vaccine Market: Doses Administered (in Million), 2016-2021
Figure 79: India: Hepatitis B Vaccine Market: Sales Value (in INR Million), 2016-2021
Figure 80: India: Hepatitis B Vaccine Market: Breakup by Prescriber (in %), 2021
Figure 81: India: Hepatitis B Vaccine Market: Breakup by Sector (in %), 2021
Figure 82: India: Hepatitis B Vaccine Market: Sales Value Forecast (in INR Million), 2022-2027
Figure 83: India: Pneumococcal Vaccine Market: Doses Administered (in Million), 2016-2021
Figure 84: India: Pneumococcal Vaccine Market: Sales Value (in INR Million), 2016-2021
Figure 85: India: Pneumococcal Vaccine Market: Breakup by Prescriber (in %), 2021
Figure 86: India: Pneumococcal Vaccine Market: Breakup by Sector (in %), 2021
Figure 87: India: Pneumococcal Vaccine Market: Sales Value Forecast (in INR Million), 2022-2027
Figure 88: India: Meningococcal Vaccine Market: Doses Administered (in '000), 2015-2021
Figure 89: India: Meningococcal Vaccine Market: Sales Value (in INR Million), 2015-2021
Figure 90: India: Meningococcal Vaccine Market: Breakup by Import and Domestic Manufacturing (in %), 2021
Figure 91: India: Meningococcal Vaccine Market: Breakup by Sector (in %), 2021
Figure 92: India: Meningococcal Vaccine Market: Sales Value Forecast (in INR Million), 2022-2027
Figure 93: India: Rabies Vaccine Market: Doses Administered (in Million), 2016-2021
Figure 94: India: Rabies Vaccine Market: Sales Value (in INR Million), 2016-2021
Figure 95: India: Rabies Vaccine Market: Breakup by Prescriber (in %), 2021
Figure 96: India: Rabies Vaccine Market: Breakup by Sector (in %), 2021
Figure 97: India: Rabies Vaccine Market: Sales Value Forecast (in INR Million), 2022-2027
Figure 98: India: HPV Vaccine Market: Doses Administered (in '000), 2016-2021
Figure 99: India: HPV Vaccine Market: Sales Value (in INR Million), 2016-2021
Figure 100: India: HPV Vaccine Market: Breakup by Prescriber (in %), 2021
Figure 101: India: HPV Vaccine Market: Breakup by Sector (in %), 2021
Figure 102: India: HPV Vaccine Market: Sales Value Forecast (in INR Million), 2022-2027
Figure 103: India: Hexavalent Vaccine Market: Doses Administered (in Million), 2017 - 2021
Figure 104: India: Hexavalent Vaccine Market: Sales Value (in INR Million), 2017 - 2021
Figure 105: India: Hexavalent Vaccine Market: Breakup by Import and Domestic Manufacturing (in %), 2021
Figure 106: India: Hexavalent Vaccine Market: Breakup by Sector (in %), 2021
Figure 107: India: Hexavalent Vaccine Market Forecast: Sales Value (in INR Million), 2022-2027
Figure 108: India: Dengue Vaccine Market: Sales Value Forecast (in INR Million), 2022-2027
Figure 109: India: Vaccine Market: SWOT Analysis
Figure 110: India: Vaccine Market: Value Chain Analysis
Figure 111: India: Vaccine Market: Price Analysis
Figure 112: India: Vaccines Market: Standard Procedure of Introducing New Vaccine
List of Tables
Table 1: India: Vaccine Market: Key Industry Highlights, 2021 and 2027
Table 2: India: BCG Vaccine: Overview
Table 3: India: HIB Vaccine: Overview
Table 4: India: Influenza Vaccine: Overview
Table 5: India: Varicella Vaccine: Overview
Table 6: India: Typhoid Vaccine: Overview
Table 7: India: JE Vaccine: Overview
Table 8: India: Measles Vaccine: Overview
Table 9: India: Tetanus Toxoid Vaccine: Overview
Table 10: India: Hepatitis A Vaccine: Overview
Table 11: India: Rubella Vaccine: Overview
Table 12: India: DPT Vaccine: Overview
Table 13: India: OPV Vaccine: Overview
Table 14: India: MMR Vaccine: Overview
Table 15: India: Rotavirus Vaccine: Overview
Table 16: India: Hepatitis B Vaccine: Overview
Table 17: India: Pneumococcal Vaccine: Overview
Table 18: India: Meningococcal Vaccine: Overview
Table 19: India: Rabies Vaccine: Overview
Table 20: India: HPV Vaccine: Overview
Table 21: India: Hexavalent Vaccine: Overview
Table 22: India: Vaccine Market: Key Components in Drug Delivery